SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001104659-24-000347
Filing Date
2024-01-02
Accepted
2024-01-02 16:26:42
Documents
10

Document Format Files

Seq Description Document Type Size
1 DEFM14A tm2332464-4_defm14a.htm DEFM14A 2391866
2 GRAPHIC hd_commonwealth-bw.jpg GRAPHIC 34111
3 GRAPHIC lg_goldmansach-bw.jpg GRAPHIC 5707
4 GRAPHIC lg_lazard-bw.jpg GRAPHIC 5530
5 GRAPHIC px_23immunogenproxy1pg01-bw.jpg GRAPHIC 267516
6 GRAPHIC px_23immunogenproxy1pg02-bw.jpg GRAPHIC 235797
7 GRAPHIC sg_goldmansach-bw.jpg GRAPHIC 9017
8 GRAPHIC sg_markjenyedy-bw.jpg GRAPHIC 6825
9 GRAPHIC sg_stephencmccluski-bw.jpg GRAPHIC 8337
10 GRAPHIC sg_stephensands-bw.jpg GRAPHIC 6789
  Complete submission text file 0001104659-24-000347.txt   3161945
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 000-17999 | Film No.: 24502798
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)